S&P 500   5,081.63 (+0.23%)
DOW   38,898.63 (-0.13%)
QQQ   437.93 (+0.61%)
AAPL   180.03 (-0.77%)
MSFT   409.55 (+0.45%)
META   489.05 (+1.04%)
GOOGL   137.24 (+0.63%)
AMZN   174.95 (+1.03%)
TSLA   199.87 (-1.07%)
NVDA   792.80 (+2.08%)
NIO   5.67 (+4.42%)
AMD   190.45 (+7.88%)
BABA   74.06 (-0.71%)
T   16.99 (+0.18%)
F   12.40 (+0.81%)
MU   89.85 (+0.16%)
CGC   3.27 (-2.68%)
GE   156.02 (+0.26%)
DIS   111.23 (+0.39%)
AMC   4.29 (-14.03%)
PFE   26.77 (-1.00%)
PYPL   60.23 (-0.03%)
XOM   104.55 (+0.22%)
S&P 500   5,081.63 (+0.23%)
DOW   38,898.63 (-0.13%)
QQQ   437.93 (+0.61%)
AAPL   180.03 (-0.77%)
MSFT   409.55 (+0.45%)
META   489.05 (+1.04%)
GOOGL   137.24 (+0.63%)
AMZN   174.95 (+1.03%)
TSLA   199.87 (-1.07%)
NVDA   792.80 (+2.08%)
NIO   5.67 (+4.42%)
AMD   190.45 (+7.88%)
BABA   74.06 (-0.71%)
T   16.99 (+0.18%)
F   12.40 (+0.81%)
MU   89.85 (+0.16%)
CGC   3.27 (-2.68%)
GE   156.02 (+0.26%)
DIS   111.23 (+0.39%)
AMC   4.29 (-14.03%)
PFE   26.77 (-1.00%)
PYPL   60.23 (-0.03%)
XOM   104.55 (+0.22%)
S&P 500   5,081.63 (+0.23%)
DOW   38,898.63 (-0.13%)
QQQ   437.93 (+0.61%)
AAPL   180.03 (-0.77%)
MSFT   409.55 (+0.45%)
META   489.05 (+1.04%)
GOOGL   137.24 (+0.63%)
AMZN   174.95 (+1.03%)
TSLA   199.87 (-1.07%)
NVDA   792.80 (+2.08%)
NIO   5.67 (+4.42%)
AMD   190.45 (+7.88%)
BABA   74.06 (-0.71%)
T   16.99 (+0.18%)
F   12.40 (+0.81%)
MU   89.85 (+0.16%)
CGC   3.27 (-2.68%)
GE   156.02 (+0.26%)
DIS   111.23 (+0.39%)
AMC   4.29 (-14.03%)
PFE   26.77 (-1.00%)
PYPL   60.23 (-0.03%)
XOM   104.55 (+0.22%)
S&P 500   5,081.63 (+0.23%)
DOW   38,898.63 (-0.13%)
QQQ   437.93 (+0.61%)
AAPL   180.03 (-0.77%)
MSFT   409.55 (+0.45%)
META   489.05 (+1.04%)
GOOGL   137.24 (+0.63%)
AMZN   174.95 (+1.03%)
TSLA   199.87 (-1.07%)
NVDA   792.80 (+2.08%)
NIO   5.67 (+4.42%)
AMD   190.45 (+7.88%)
BABA   74.06 (-0.71%)
T   16.99 (+0.18%)
F   12.40 (+0.81%)
MU   89.85 (+0.16%)
CGC   3.27 (-2.68%)
GE   156.02 (+0.26%)
DIS   111.23 (+0.39%)
AMC   4.29 (-14.03%)
PFE   26.77 (-1.00%)
PYPL   60.23 (-0.03%)
XOM   104.55 (+0.22%)
OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

$0.28
0.00 (0.00%)
(As of 02/28/2024 ET)
Today's Range
$0.28
$0.30
50-Day Range
$0.27
$0.38
52-Week Range
$0.25
$0.55
Volume
340,747 shs
Average Volume
490,638 shs
Market Capitalization
$105.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MariMed MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.82mentions of MariMed in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.02) to ($0.01) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.67 out of 5 stars


MRMD stock logo

About MariMed Stock (OTCMKTS:MRMD)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; chewable cannabis-infused mint tablet under the brand Kalm Fusion. It also provides soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand. In addition, the company offers vapes, and edible products under InHouse brand. Further, it provides company licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

MRMD Stock Price History

MRMD Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
MariMed Closes $58.7 Million Debt Refinancing
MariMed Inc. (PNK:MRMD) Q3 2023 Earnings Call Transcript
MariMed Inc.: MariMed Reports Third Quarter 2023 Earnings
MariMed Reports Third Quarter 2023 Earnings
Earnings Preview: MariMed
See More Headlines
Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
2/29/2024
Next Earnings (Estimated)
3/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:MRMD
Fax
N/A
Employees
592
Year Founded
N/A

Profitability

Net Income
$13.47 million
Pretax Margin
3.98%

Debt

Sales & Book Value

Annual Sales
$134.01 million
Cash Flow
$0.06 per share
Book Value
$0.17 per share

Miscellaneous

Free Float
298,630,000
Market Cap
$105.24 million
Optionable
Not Optionable
Beta
2.92
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Jon R. Levine (Age 59)
    Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director
    Comp: $481.74k
  • Mr. Timothy Shaw (Age 46)
    Chief Operating Officer
    Comp: $445.86k
  • Mr. Jonathan W. Rider (Age 59)
    Chief Information Officer
  • Mr. Steve Wayne West
    Vice President of Investor Relations
  • Mr. Howard Schacter
    Chief Communications Officer
  • Ms. Sara Gullickson (Age 39)
    Vice President of Marketing
  • Mr. Ryan Crandall
    Chief Revenue Officer
  • Mr. Charles Holt Finnie
    Chief Strategy Officer














MRMD Stock Analysis - Frequently Asked Questions

How have MRMD shares performed in 2024?

MariMed's stock was trading at $0.2748 at the start of the year. Since then, MRMD stock has increased by 1.9% and is now trading at $0.28.
View the best growth stocks for 2024 here
.

Are investors shorting MariMed?

MariMed saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 10,200 shares, a decline of 46.6% from the January 31st total of 19,100 shares. Based on an average daily volume of 1,275,100 shares, the short-interest ratio is currently 0.0 days.
View MariMed's Short Interest
.

When is MariMed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 6th 2024.
View our MRMD earnings forecast
.

How were MariMed's earnings last quarter?

MariMed Inc. (OTCMKTS:MRMD) issued its quarterly earnings results on Monday, November, 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The company earned $33.21 million during the quarter. MariMed had a negative net margin of 0.76% and a positive trailing twelve-month return on equity of 3.54%.

What other stocks do shareholders of MariMed own?
How do I buy shares of MariMed?

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MRMD) was last updated on 2/29/2024 by MarketBeat.com Staff